Arthur M. Cohen & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.7M | Buy |
10,636
+1,636
| +18% | +$381K | 0.42% | 40 |
|
|
2026
Q1 | $2.2M | Buy |
9,000
+725
| +9% | +$169K | 0.39% | 44 |
|
|
2025
Q4 | $1.71M | Buy |
8,275
+675
| +9% | +$133K | 0.28% | 46 |
|
|
2025
Q3 | $1.41M | Sell |
7,600
-125
| -2% | -$21.4K | 0.24% | 55 |
|
|
2025
Q2 | $1.18M | Sell |
7,725
-388
| -5% | -$59.6K | 0.21% | 60 |
|
|
2025
Q1 | $1.35M | Hold |
8,113
| – | – | 0.26% | 50 |
|
|
2024
Q4 | $1.17M | Sell |
8,113
-2,107
| -21% | -$327K | 0.21% | 60 |
|
|
2024
Q3 | $1.66M | Buy |
10,220
+34
| +0.3% | +$5.42K | 0.3% | 43 |
|
|
2024
Q2 | $1.49M | Sell |
10,186
-1,007
| -9% | -$150K | 0.27% | 45 |
|
|
2024
Q1 | $1.77M | Sell |
11,193
-1,312
| -10% | -$209K | 0.37% | 40 |
|
|
2023
Q4 | $1.96M | Sell |
12,505
-3,690
| -23% | -$566K | 0.46% | 35 |
|
|
2023
Q3 | $2.52M | Sell |
16,195
-101
| -0.6% | -$16.7K | 0.65% | 26 |
|
|
2023
Q2 | $2.7M | Sell |
16,296
-252
| -2% | -$40.7K | 0.67% | 26 |
|
|
2023
Q1 | $2.56M | Buy |
16,548
+885
| +6% | +$143K | 0.69% | 25 |
|
|
2022
Q4 | $2.77M | Sell |
15,663
-1,401
| -8% | -$242K | 0.76% | 26 |
|
|
2022
Q3 | $2.79M | Sell |
17,064
-101
| -0.6% | -$17.1K | 0.77% | 26 |
|
|
2022
Q2 | $3.05M | Buy |
17,165
+130
| +0.8% | +$23.2K | 0.76% | 26 |
|
|
2022
Q1 | $3.02M | Sell |
17,035
-5,554
| -25% | -$945K | 0.64% | 31 |
|
|
2021
Q4 | $3.86M | Sell |
22,589
-110
| -0.5% | -$18K | 0.72% | 29 |
|
|
2021
Q3 | $3.67M | Sell |
22,699
-20
| -0.1% | -$3.41K | 0.74% | 28 |
|
|
2021
Q2 | $3.74M | Buy |
22,719
+35
| +0.2% | +$5.79K | 0.73% | 28 |
|
|
2021
Q1 | $3.73M | Sell |
22,684
-1,035
| -4% | -$167K | 0.86% | 24 |
|
|
2020
Q4 | $3.73M | Buy |
23,719
+500
| +2% | +$73.8K | 0.88% | 24 |
|
|
2020
Q3 | $3.46M | Sell |
23,219
-295
| -1% | -$43.7K | 0.9% | 23 |
|
|
2020
Q2 | $3.31M | Buy |
23,514
+150
| +0.6% | +$21.9K | 1% | 20 |
|
|
2020
Q1 | $3.01M | Sell |
23,364
-1,770
| -7% | -$251K | 1.19% | 20 |
|
|
2019
Q4 | $3.67M | Sell |
25,134
-7,705
| -23% | -$1.05M | 1.13% | 19 |
|
|
2019
Q3 | $4.25K | Sell |
32,839
-2,534
| -7% | -$334K | 1.2% | 17 |
|
|
2019
Q2 | $4.93M | Sell |
35,373
-5,478
| -13% | -$758K | 1.69% | 15 |
|
|
2019
Q1 | $5.71M | Buy |
40,851
+3,597
| +10% | +$482K | 2.04% | 13 |
|
|
2018
Q4 | $5.1K | Sell |
37,254
-1,263
| -3% | -$176K | 1.62% | 15 |
|
|
2018
Q3 | $5.33K | Sell |
38,517
-1,825
| -5% | -$243K | 1.62% | 13 |
|
|
2018
Q2 | $4.9M | Sell |
40,342
-1,170
| -3% | -$146K | 1.85% | 13 |
|
|
2018
Q1 | $5.2M | Buy |
41,512
+1,199
| +3% | +$162K | 1.96% | 13 |
|
|
2017
Q4 | $5.2K | Buy |
+40,313
| New | +$5.62M | 1.43% | 15 |
|
|
2017
Q2 | $5.41M | Sell |
40,690
-2,597
| -6% | -$331K | 2.12% | 11 |
|
|
2017
Q1 | $5.4M | Buy |
43,287
+383
| +0.9% | +$45.8K | 2.41% | 9 |
|
|
2016
Q4 | $4.94M | Buy |
+42,904
| New | +$4.96M | 2.62% | 7 |
|
|
2014
Q3 | $5.4M | Buy |
+41,498
| New | +$4.3M | 2.51% | 10 |
|
Other funds holding JNJ
Arthur M. Cohen & Associates's JNJ Position: Q2 2026 in Review
Arthur M. Cohen & Associates increased its Johnson & Johnson (JNJ) stake by 18% in Q2 2026, buying an estimated $381K and bringing the position to 10,636 shares worth $2.7M. The position accounts for 0.42% of the portfolio, ranked #40.
Arthur M. Cohen & Associates first reported a position in JNJ in Q3 2014 and has held it in 39 quarters since. The position peaked at $5.71M in Q1 2019. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Arthur M. Cohen & Associates held 10,636 shares of Johnson & Johnson worth $2.7M as of Q2 2026.
- Arthur M. Cohen & Associates bought 1,636 Johnson & Johnson shares in Q2 2026, an estimated $381K.
- Johnson & Johnson made up 0.42% of Arthur M. Cohen & Associates's portfolio in Q2 2026, its #40 holding.
- Arthur M. Cohen & Associates first reported a position in Johnson & Johnson in Q3 2014 and has held it in 39 quarters since.
- Arthur M. Cohen & Associates's Johnson & Johnson position peaked at $5.71M in Q1 2019.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Arthur M. Cohen & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.